Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Efficacy of Fujirebio antiulcer drug demonstrated

Jan. 21, 1997

Panax acquires colon-clearing drug for colonoscopy preparation

Jan. 17, 1997

Prokinetic agents disclosed by Zeria

Jan. 16, 1997

HemoCleanse licenses bioartificial liver technology from Monsanto

Jan. 14, 1997

OXIS files IND for BXT-51072

Jan. 13, 1997

VIMRxyn enters clinical testing in HCV-infected patients

Jan. 9, 1997

ISIS-2302 update

Jan. 9, 1997

Oxis International completes phase I testing of IBD treatment

Jan. 8, 1997

Anti-HCV agents revealed by Japanese and Chinese investigators

Jan. 8, 1997

Prokinetic agents from Tokyo Tanabe

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...